HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 298 filers reported holding HAEMONETICS CORP in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,957,144 | -68.4% | 21,848 | -70.0% | 0.00% | -66.7% |
| Q2 2023 | $6,194,190 | +12.7% | 72,753 | -29.8% | 0.01% | +20.0% |
| Q4 2021 | $5,494,000 | +342.4% | 103,583 | +890.4% | 0.01% | +42.9% |
| Q4 2020 | $1,242,000 | -83.6% | 10,459 | -88.0% | 0.01% | -85.7% |
| Q3 2020 | $7,583,000 | +122.0% | 86,911 | +127.9% | 0.05% | +104.2% |
| Q2 2020 | $3,415,000 | +728.9% | 38,132 | +964.2% | 0.02% | +700.0% |
| Q4 2019 | $412,000 | -97.8% | 3,583 | -97.6% | 0.00% | -98.0% |
| Q2 2019 | $18,335,000 | +109.7% | 152,363 | +52.4% | 0.15% | +268.3% |
| Q1 2019 | $8,744,000 | +4207.4% | 99,958 | +4324.9% | 0.04% | +1266.7% |
| Q2 2018 | $203,000 | -7.7% | 2,259 | -25.0% | 0.00% | -66.7% |
| Q1 2018 | $220,000 | -70.7% | 3,013 | -88.4% | 0.01% | +50.0% |
| Q2 2016 | $752,000 | -70.5% | 25,949 | -64.3% | 0.01% | -76.0% |
| Q1 2016 | $2,546,000 | – | 72,771 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
| HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
| Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
| Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
| ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
| Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
| Dean Capital Management | 15,309 | $812,000 | 0.70% |
| Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |